DE60312002D1 - Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration - Google Patents

Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration

Info

Publication number
DE60312002D1
DE60312002D1 DE60312002T DE60312002T DE60312002D1 DE 60312002 D1 DE60312002 D1 DE 60312002D1 DE 60312002 T DE60312002 T DE 60312002T DE 60312002 T DE60312002 T DE 60312002T DE 60312002 D1 DE60312002 D1 DE 60312002D1
Authority
DE
Germany
Prior art keywords
modifyer
clathrate
nanofiltration
proteins
require transition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60312002T
Other languages
English (en)
Other versions
DE60312002T2 (de
Inventor
Barry Rosenblatt
Richard Siegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29736709&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60312002(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of DE60312002D1 publication Critical patent/DE60312002D1/de
Application granted granted Critical
Publication of DE60312002T2 publication Critical patent/DE60312002T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/027Nanofiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/04Feed pretreatment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/04Specific process operations in the feed stream; Feed pretreatment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DE60312002T 2002-06-14 2003-06-04 Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration Expired - Lifetime DE60312002T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39473302P 2002-06-14 2002-06-14
US394733P 2002-06-14
PCT/US2003/017482 WO2003105989A1 (en) 2002-06-14 2003-06-04 Use of a clathrate modifier to promote passage of proteins during nanofiltration

Publications (2)

Publication Number Publication Date
DE60312002D1 true DE60312002D1 (de) 2007-04-05
DE60312002T2 DE60312002T2 (de) 2007-08-23

Family

ID=29736709

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60312002T Expired - Lifetime DE60312002T2 (de) 2002-06-14 2003-06-04 Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration

Country Status (11)

Country Link
US (1) US6773600B2 (de)
EP (1) EP1534404B1 (de)
JP (1) JP2005529948A (de)
AT (1) ATE354418T1 (de)
AU (1) AU2003239959A1 (de)
CA (1) CA2489123C (de)
DE (1) DE60312002T2 (de)
DK (1) DK1534404T3 (de)
ES (1) ES2282638T3 (de)
PT (1) PT1534404E (de)
WO (1) WO2003105989A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2655897C (en) * 2006-06-26 2015-09-29 Omrix Biopharmaceuticals Inc. Virus removal by nanofiltration
EP2155454A4 (de) * 2007-05-14 2011-12-07 Lulu Gilbert Gal Ben System und verfahren für einen gesteuerten prozess zur herstellung von gemischen aus leichten baumaterialien und system zur automatischen herstellung von leichten mauersteinen
US7681732B2 (en) 2008-01-11 2010-03-23 Cryovac, Inc. Laminated lidstock
US8354132B2 (en) * 2008-06-06 2013-01-15 Cryovac, Inc. Laminated lidstock and package made therefrom
TR201810703T4 (tr) * 2011-03-25 2018-08-27 Hoffmann La Roche Yeni protein saflaştırma yöntemleri.
EP3418290A1 (de) 2013-08-08 2018-12-26 CSL Ltd. Verfahren zur entfernung von verunreinigungen
WO2015140751A1 (en) * 2014-03-21 2015-09-24 Boreal Invest Terminal nanofiltration of solubilized protein compositions for removal of immunogenic aggregates
EP4218991A1 (de) 2014-05-13 2023-08-02 Amgen Inc. Prozesssteuerungssysteme und verfahren zur verwendung mit filtern und filtrationsverfahren
EP3187582A4 (de) * 2014-08-27 2018-03-28 Godo Shusei Co., Ltd. Laktaselösung und milch damit
US10991942B2 (en) 2018-03-23 2021-04-27 EnPower, Inc. Electrochemical cells having one or more multilayer electrodes
US10998553B1 (en) 2019-10-31 2021-05-04 EnPower, Inc. Electrochemical cell with integrated ceramic separator
US11594784B2 (en) 2021-07-28 2023-02-28 EnPower, Inc. Integrated fibrous separator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789482A (en) 1986-02-10 1988-12-06 Millipore Corporation Method for separating liquid compositions on the basis of molecular weight
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
AT401595B (de) 1995-05-18 1996-10-25 Viennatone Ag Hörgerät
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process

Also Published As

Publication number Publication date
CA2489123A1 (en) 2003-12-24
EP1534404A1 (de) 2005-06-01
US6773600B2 (en) 2004-08-10
ATE354418T1 (de) 2007-03-15
PT1534404E (pt) 2007-03-30
EP1534404A4 (de) 2005-09-28
AU2003239959A1 (en) 2003-12-31
US20030230532A1 (en) 2003-12-18
EP1534404B1 (de) 2007-02-21
JP2005529948A (ja) 2005-10-06
DE60312002T2 (de) 2007-08-23
DK1534404T3 (da) 2007-05-07
CA2489123C (en) 2011-03-15
ES2282638T3 (es) 2007-10-16
WO2003105989A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
DE60312002D1 (de) Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration
CA2553640C (en) Novel canola protein isolate
ME00185B (me) Specifični agensi koji vezuju humani angiopoetin-2
DE60303373D1 (de) Verfahren zur entschwefelung von erdgas.
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
ATE278706T1 (de) Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen
BRPI0408385B1 (pt) meio de filtro compàsito.
ATE463467T1 (de) Wasserbehandlungsverfahren
ATE291955T1 (de) Biologischer filter zur reinigung von abgasen
ATE446314T1 (de) Methode zur reinigung von fsh
ATE283277T1 (de) Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration
ATE554133T1 (de) Verfahren zur extraktion von polyamid aus abfallstoffen
ATE417056T1 (de) Verfahren zur proteinreinigung
ATE403483T1 (de) Fest-flüssig-filtrationstuch und - filtervorrichtung
ATE434036T1 (de) Filtrationsverfahren zur trennung von viren
DE60100565D1 (de) Verfahren zur Reinigung von Phosphatidylserin
HRP20110927T1 (hr) Protutlačna filtracija proteina
AR060686A1 (es) Purificacion de trombina
FR2861395B1 (fr) Facteur viii viralement securise a faible teneur en multimeres superieurs
ATE250132T1 (de) Verfahren zur extraktion von periplasmatischen proteinen aus prokaryotischen mikroorganismen in der anwesenheit von arginin
DE60312753D1 (de) System zur Entfernung von Partikeln
ATE412027T1 (de) Verfahren zur delaminierung von mehrschichtigem laminiertem industrieverpackungsabfall
ATE339389T1 (de) Verfahren zur reinigung von kerzenfiltern und membrananlagen
DE602006012360D1 (de) Verfahren zur aufreinigung von vancomycin
ATE334141T1 (de) Gebrauch von viren zum aufspüren oder säubern von proteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition